Aim: Abnormal uterine bleeding (AUB) is a common cause for gynecological referrals. Serum correlation of hormone levels along with study of expression of estrogen receptor (ER) and progesterone receptor (PR) in the endometrium of patients with AUB may be helpful in deciding treatment.
INTRODUCTION
Abnormal uterine bleeding is defined as an alteration in the volume, pattern, and/or duration of menstrual blood flow and remains the most common reason for gynecologic referrals. 1, 2 International Federation of Gynecology and Obstetrics (FIGO) came up with PALM-COEIN classification for AUB in nongravid women in reproductive age groups. The system is categorized into nine major categories known as PALM-COEIN. 3 The causes of PALM group are structural and measurable visually, by using imaging techniques and/or by use of histopathology, while the COEIN group is related to entities that cannot be determined by imaging or histopathology alone. 4 The AUB-endometrium may arise either due to hormonal imbalance or due to inadequate prostaglandins. 5, 6 Estrogen and progesterone exert their effect by acting on specific nuclear receptor proteins, ER and PR. These receptors are present in endometrial stromal and glandular cells. 7 The ERs and PRs are placed in nuclear steroid receptor superfamily. 8 Estrogen and progesterone mediate their effect through intra-and extranuclear receptors. The ER exists in two forms: ERα and ERβ. 9 The PR receptor occurs in PR-A and PR-B. 7 The IHC is helpful because of tissue localization and aids in assessing tissue 
MATERIALS AND METHODS
A cross-sectional study for the period from July 2014 to August 2015 was performed in patients presenting with AUB in reproductive age group in nongravid women. All endometrial specimens from patients of age group 15 to 45 years presenting with complaints of AUB were classified as per PALM-COEIN classification in nongravid women in reproductive age group. Females of age group 15 to 45 presenting with AUB were included. Any female presenting with systemic diseases like diabetes mellitus, hypertension, chronic liver and kidney disease, and organic genital tract lesion were excluded from the present study. Patients presenting with mental illness were also excluded. Endometrial biopsy was stained with H&E and examined thoroughly to note the histopathological details and classified as per FIGO (PALM-COEIN) and World Health Organization classification. In 40 AUB-E cases, serum estradiol and progesterone levels were estimated by chemiluminescence method (Immulite 1000). Midluteal phase levels were taken as normal reference range as all biopsies were obtained in premenstrual phase (normal estradiol levels = 27-246 pg/mL; normal progesterone levels = 2.83-26.1 ng/mL). The IHC for quantification of ERα and PR expression was carried out in AUB-E cases. For IHC 20 control samples were taken from hysterectomy specimen of similar age group presenting with vaginal prolapse. Primary antibody used for ERα was monoclonal mouse anti-ER clone ID5 (BioGenex, Fremont, CA) and for PR was monoclonal mouse anti-PR clone PR88 (BioGenex, Fremont, CA). A case was considered positive when brown coloration of the nucleus was observed. Expression of ERα and PR receptors was positive in endometrial lining cells as well as in stroma. Intensity and distribution of ERα and PR were evaluated using a semi-quantitative method Immunoreactive score (IRS score) 15 ( Figs 1 and 2 ).
The IRS score was calculated as follows: IRS = SI × PP, where SI is the optical staining intensity (graded as 0 = no, 1 = weak, 2 = moderate, and 3 = strong staining) and PP the percentage of positive-stained cells. The PP was estimated by counting approximately 200 cells and it was defined as 0 = no staining, 1 = <10%, 2 = 11 to 50%, 3 = 51 to 80% and 4 = >81. Unpaired Student's t-test was performed to compare the results in various groups. A p-value ≤ 0.05 was taken as critical level of significance.
RESULTS
In AUB-E cases, serum estradiol and progesterone were compared with normal reference range of our laboratory and they were classified as having decreased, normal, or increased levels Out of 40 cases studied 4/40 (10%) had decreased serum estradiol levels, 26/40 (65%) cases had normal serum estradiol levels, 10/40 (25%) cases had increased serum estradiol levels. Serum progesterone was decreased in 21/40 (52.5%), normal in 12/40 (30%), and increased in 7/40 (17.5%) ( Table 1 ). When serum progesterone levels were evaluated in relation to serum estradiol levels, in four cases with decreased serum estradiol levels progesterone levels were also decreased. Out of 26 cases with normal serum estradiol levels, 9/26 (34.61%) cases had normal serum progesterone levels, 16/26 (61.54%) cases had decreased serum progesterone levels, and 1/26 (3.85%) case had increased serum progesterone levels. Out of 10 cases of increased serum estradiol levels, 3/10 (30%) cases had normal, 1/10 (10%) had decreased, and 6/10 (60%) cases had increased serum progesterone levels (Graph 1). When status of ERα expression in patients with normal estradiol levels but variable progesterone was evaluated in cases with decreased or normal serum progesterone, expression of ERα in glands was more as compared with stroma. One case with increased serum level had increased ERα expression in stroma as compared with glands (Table 2) , thus highlighting the role of serum progesterone in stromal expression of ERα.
The ERα expression when correlated with serum estradiol in four cases with decreased serum estradiol levels (17.6 pg/mL) had maximum scores (20.5). Twentysix cases with normal serum estradiol levels (101.146 pg/ mL) had total score (16.96) more than increased group (13.5). Ten cases with increased serum estradiol levels had lowest ERα (13.5) and mean serum values were maximum (1,389.3). When mean [standard deviation (SD)] ERα expression of patients with increased serum estradiol of the lowest (13.5) was compared with those of decreased serum estradiol levels (20.5), the difference was found to be statistically significant (p < 0.0432) (Graph 2), thus establishing an inverse relation between serum estradiol levels and ERα expression. When levels of serum estradiol were compared with ER expression a clear inverse relation was observed. Patients with increases in serum estradiol (mean SD 1389.3) had ER score (13.5) in contrast to decreased serum estradiol levels (17.6 pg/mL) where ER score was 20.5.
PR receptor expression was not considered very significant because it did not show any significant variation to hyperestrogenic state.
DISCUSSION
Of 40 patients in whom serum estradiol levels were measured, 10% had decreased, 65% had normal, and 25% showed increased levels. Serum progesterone levels were decreased in 52.5%, normal in 30%, and increased in 17.5%, thereby highlighting hormonal discrepancy in cases of AUB. When serum progesterone was evaluated in relation to serum estradiol levels, 10% cases with decreased serum estradiol had decreased progesterone levels, also highlighting the hormonal insufficiency. Out of 65% cases where serum levels of estradiol were normal, serum progesterone levels of 34.61% were also normal, implying local factors like endothelins or prostaglandins as the cause of AUB; 61.53% had decreased serum levels of progesterone, thereby creating a relative hyperestrogenic state. It is known that unopposed estrogen leads to excessive endometrial proliferation and hyperplasia with raised and dilated draining veins and suppression of spiral arterioles. 16 Unopposed estrogen leads to direct effect on uterine blood supply by causing decreased vascular tone, 17 which may be an indirect effect through inhibiting vasopressin release 18 causing vasodilation and increased blood flow. Unopposed estrogen also increases stromal vascular endothelial growth factor expression that may lead to disrupted angiogenesis. 19 Additionally, endometrium exposed to prolonged estrogen produces less prostaglandin and more of prostaglandin E than prostaglandin F. 20 In 3.84% where progesterone was increased probably stromal or vascular factors may be responsible for AUB. 5, 6 In cases with increased serum estradiol levels, progesterone levels were normal in 30% and low in 10% but none had higher levels, thus creating a hyperestrogenic state causing AUB; 60% cases who presented with high progesterone levels in this group had disproportionally high (>2,000 pg/mL) serum estradiol levels, thus again creating a relatively hyperestrogenic state causing AUB. [16] [17] [18] [19] [20] When ERα receptor expression was assessed in relation to serum estradiol levels, a decreasing trend in expression of ERα receptor was found with increased levels of mean estradiol levels. Patients with decreased serum estradiol (17.6 pg/mL) had mean receptor expression score of 20.5, whereas patients with markedly increased serum estradiol levels (1,389.3 pg/mL) had mean ERα expression of 13.5 only. Difference between two groups was statistically significant (p < 0.04), thus highlighting that both serum estradiol levels and expression of ER have a role in the process of hyperestrogenemia and probably patients with decreased serum estradiol levels present with changes of hyperestrogenesim due to overexpression of ERα receptors.
No well-documented study could be found in literature comparing the serum hormone levels with expression of tissue receptor except by Chakravarthy et al 21 who also noted discrepancy in patients presenting with dysfunctional uterine bleeding (term discouraged by FIGO now) but details were not specified. One of the limitations of the study was the small sample size since the duration of the study was short, and a larger study is required to further validate the results. High cost of assessment of serum hormone levels and tissue ERα receptor may be a distracting factor but when considered in relation to suboptimal therapy/unwanted prolonged hormonal therapy it may not appear expensive.
CONCLUSION
In AUB-E cases a hyperestrogenic state may be due to true/ relative increase in serum estradiol levels. Both expression of receptors in endometrium and serum hormone levels play a role in final outcome of hyperestrogenic state.
Therefore, patients with AUB-E with normal or decreased serum estradiol may be investigated for expression of ERα in endometrium for deciding the final line of treatment.
CLINICAL SIGNIfICANCE
As hormonal imbalance is a key mechanism for AUB, patients presenting with AUB-E with normal or decreased hormonal levels should be investigated for ERα in endometrial biopsy to decide optimal hormonal therapy as expression of receptors in endometrium and serum hormone levels play a role in final outcome of hyperestrogenic state.
